Peripheral Angioplasty Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Autologous CD133(+) Cells as an Adjuvant to Below the Knee Percutaneous Transluminal Angioplasty
Condition: Peripheral Arterial Disease Interventions: Biological: G-CSF + CD133(+) cells; Biological: G-CSF; Procedure: percutaneous transluminal angioplasty (PTA); Biological: Placebo infusion Sponsor: Shanghai 10th People's Hospital Recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 22, 2016 Category: Research Source Type: clinical trials

Impact of routine coronary catheterization in low extremity artery disease undergoing percutaneous transluminal angioplasty: study protocol for a multi-center randomized controlled trial
Discussion The results of the trial will, for the first time, support better decision-making for coronary evaluation before PTA in LEAD. If favorable, routine coronary angiography followed by revascularization will improve cardiovascular outcomes in LEAD patients undergoing PTA. Trial registration ClinicalTrials.gov identifier: NCT02169258 (registered on 21 June 2014); registry name: Routine Coronary Catheterization in Low Extremity Artery Disease Undergoing Percutaneous Transluminal Angioplasty (PIROUETTE-PTA). (Source: Trials)
Source: Trials - February 29, 2016 Category: Research Source Type: clinical trials

Percutaneous Transluminal Angioplasty Registry
Condition: Percutaneous Transluminal AngioplastyIntervention: Sponsor: Klinik für Kardiologie, Pneumologie und AngiologieRecruiting - verified March 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 18, 2016 Category: Research Source Type: clinical trials